KDM4A and prostate carcinoma: Downregulation of JMJD2A inhibited prostate cancer cell growth, whereas its overexpression in a transgenic mouse model led to the formation of prostatic intraepithelial neoplasia and cooperated with ETV1 to induce adenocarcinoma.